HLA and non-HLA genetic analyses reveal suggestive variants associated with statin-induced liver injury
Callie Jo Zaborenko, Tae-Hwi Schwantes-An, Yi-Ju Li, Andrew Dellinger, Paola Nicoletti, Ann K. Daly, Guruprasad Aithal, Naga Chalasani,Background:
Statins are widely prescribed for cardiovascular risk reduction and are generally well tolerated. However, they can cause drug-induced liver injury (DILI), and the genetic factors contributing to statin-DILI remain poorly understood.
Methods:
Results:
Conclusion:
We identified